Mark Hogendobler

Mark Hogendobler has an extensive background in business development, sales, and management roles within the healthcare and technology industries. Mark has worked in companies like OM1, Curebase, uMed, AiCure, and more, focusing on areas such as real-world data, decentralized clinical trials, AI solutions, and remote patient engagement in clinical trials. Their experience includes building out evidence generation networks, targeting and closing opportunities with biopharma sponsors, strategic business development, and sales management. Mark's career has involved working with leading companies to drive innovation and improve patient outcomes through data-driven solutions.

Mark Hogendobler graduated in 1987 with a BA in Molecular Biology, summa cum laude, from Princeton University.